INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

MINUTES OF PROCEEDINGS

Meeting No. 55

Monday, April 23, 2007

The Standing Committee on Industry, Science and Technology met at 3:30 p.m. this day, in Room 371, West Block, the Chair, James Rajotte, presiding.

Members of the Committee present: André Arthur, Hon. Scott Brison, Paule Brunelle, Colin Carrie, Brian Masse, Hon. Dan McTeague, James Rajotte, Bev Shipley and Dave Van Kesteren.

Acting Members present: Paul Crête for Robert Vincent.

In attendance: Library of Parliament: Lalita Acharya, Analyst ; Dan Shaw, Analyst.

Witnesses: Gilead Sciences Inc.: Gregg Alton, Senior Vice-President and General Counsel. Canadian Generic Pharmaceutical Association: Jack Kay, Vice-Chair, President and Chief Operating Officer, Apotex Inc.; Jim Keon, President. Canada's Research-Based Pharmaceutical Companies (Rx & D): Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc.; Russell Williams, President.

Pursuant to Standing Order 108(2) and the motion adopted by the Committee on March 21, 2007, the Committee resumed its study of Canada's Access to Medicines Regime.

The witnesses made statements and answered questions.

Brian Masse moved, — That the Committee send for a response to the following question to the Canadian International Development Agency, the Department of Industry, the Department of Foreign Affairs and International Trade and the Department of Health: How much money has been spent and how many personnel hours have been utilized by government agencies to promote Canada's Access to Medecines Regime outreach programs since the passing, by Parliament, of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa) in the Third Session of the 37th Parliament?.

After debate, the question was put on the motion and it was agreed to.

At 5:34 p.m., the Committee adjourned to the call of the Chair.

James M. Latimer
Clerk of the Committee

2007/04/26 1:11 p.m.